Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William H Matsui

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Medicine|September 10, 2016
Cancer stem cell signaling pathwaysWilliam H Matsui
Medicine|September 10, 2016
Cancer stem cells: A nuanced perspectiveJeremy N Rich, William H Matsui, Jenny C Chang
Journal of the National Cancer Institute|April 22, 2004
Cancer stem cells: are we missing the target?Richard J Jones, William H Matsui, B Douglas Smith
Leukemia & Lymphoma|May 27, 2004
Enhanced cytotoxicity of rituximab following genetic and biochemical disruption of glycosylphosphatidylinositol anchored proteinsNagaprasad Nagajothi, William H Matsui, Galina L Mukhina, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2006
Strategies to eliminate cancer stem cells: clinical implicationsCarol Ann Huff, William H Matsui, B Douglas Smith, et al.
Leukemia Research|July 12, 2014
Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances the clinical responses to interferon-α (IFN) in newly diagnosed chronic myeloid leukemia (CML)Joshua F Zeidner, Douglas E Gladstone, Marianna Zahurak, et al.
Molecular Cancer Therapeutics|July 28, 2010
A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer modelN V Rajeshkumar, Zeshaan A Rasheed, Elena García-García, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 13, 2002
The role of growth factors in the activity of pharmacological differentiation agentsWilliam H Matsui, Douglas E Gladstone, Milada S Vala, et al.
The Journal of Clinical Investigation|October 25, 2016
Hedgehog and retinoid signaling alters multiple myeloma microenvironment and generates bortezomib resistanceSalvador Alonso, Daniela Hernandez, Yu-Ting Chang, et al.
Blood|December 19, 2009
High-dose cyclophosphamide for severe aplastic anemia: long-term follow-upRobert A Brodsky, Allen R Chen, Donna Dorr, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Medicine|September 10, 2016
Cancer stem cell signaling pathwaysWilliam H Matsui
Medicine|September 10, 2016
Cancer stem cells: A nuanced perspectiveJeremy N Rich, William H Matsui, Jenny C Chang
Journal of the National Cancer Institute|April 22, 2004
Cancer stem cells: are we missing the target?Richard J Jones, William H Matsui, B Douglas Smith
Leukemia & Lymphoma|May 27, 2004
Enhanced cytotoxicity of rituximab following genetic and biochemical disruption of glycosylphosphatidylinositol anchored proteinsNagaprasad Nagajothi, William H Matsui, Galina L Mukhina, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2006
Strategies to eliminate cancer stem cells: clinical implicationsCarol Ann Huff, William H Matsui, B Douglas Smith, et al.
Leukemia Research|July 12, 2014
Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances the clinical responses to interferon-α (IFN) in newly diagnosed chronic myeloid leukemia (CML)Joshua F Zeidner, Douglas E Gladstone, Marianna Zahurak, et al.
Molecular Cancer Therapeutics|July 28, 2010
A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer modelN V Rajeshkumar, Zeshaan A Rasheed, Elena García-García, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 13, 2002
The role of growth factors in the activity of pharmacological differentiation agentsWilliam H Matsui, Douglas E Gladstone, Milada S Vala, et al.
The Journal of Clinical Investigation|October 25, 2016
Hedgehog and retinoid signaling alters multiple myeloma microenvironment and generates bortezomib resistanceSalvador Alonso, Daniela Hernandez, Yu-Ting Chang, et al.
Blood|December 19, 2009
High-dose cyclophosphamide for severe aplastic anemia: long-term follow-upRobert A Brodsky, Allen R Chen, Donna Dorr, et al.
Pageof 4